SI1485084T1 - Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye - Google Patents

Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye

Info

Publication number
SI1485084T1
SI1485084T1 SI200330293T SI200330293T SI1485084T1 SI 1485084 T1 SI1485084 T1 SI 1485084T1 SI 200330293 T SI200330293 T SI 200330293T SI 200330293 T SI200330293 T SI 200330293T SI 1485084 T1 SI1485084 T1 SI 1485084T1
Authority
SI
Slovenia
Prior art keywords
ascorbic acid
eye
prepare
improving
level
Prior art date
Application number
SI200330293T
Other languages
Slovenian (sl)
Inventor
Mario Pinza
Lucia Durando
Leonardo Marchitto
Michele Virno
Original Assignee
A F S P A Aziende Chimiche Riu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2002MI000557A external-priority patent/ITMI20020557A1/en
Application filed by A F S P A Aziende Chimiche Riu filed Critical A F S P A Aziende Chimiche Riu
Publication of SI1485084T1 publication Critical patent/SI1485084T1/en

Links

SI200330293T 2002-03-15 2003-03-05 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye SI1485084T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002MI000557A ITMI20020557A1 (en) 2002-03-15 2002-03-15 USE OF A SALT OF L-ASCORBIC ACID TO PREPARE A PHARMACEUTICAL COMPOSITION FOR TOPICAL OPHTHALMIC USE CAPABLE OF IMPROVING THE LEVEL D
PCT/EP2003/002258 WO2003077905A1 (en) 2002-03-15 2003-03-05 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophtalmic topical use capable of improving the level of l-ascorbic acid in the eye
EP03744341A EP1485084B9 (en) 2002-03-15 2003-03-05 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye

Publications (1)

Publication Number Publication Date
SI1485084T1 true SI1485084T1 (en) 2006-08-31

Family

ID=36951196

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330293T SI1485084T1 (en) 2002-03-15 2003-03-05 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye

Country Status (1)

Country Link
SI (1) SI1485084T1 (en)

Similar Documents

Publication Publication Date Title
WO2006078659A3 (en) Stable prostaglandin-containing compositions
HK1118721A1 (en) Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops l- l-
WO2004072085A3 (en) Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
ZA200409862B (en) Benzofused heteroaryl derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
IL186544A (en) Use of 1,3-propanedisulfonic acid or its sodium salt in the preparation of a pharmaceutical formulation for the treatment of aa amyloidosis and a pharmaceutical formulation for the treatment of aa amyloidosis
BRPI0407845A (en) intranasal formulation of rotigotine
HK1197065A1 (en) New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
HK1086492A1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'- fluoroanilino)phenylacetic acid
EP1602362A4 (en) Drug composition having active ingredient adhered at high concentration to spherical core
PL1660047T3 (en) Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2004032873A3 (en) Therapeutic combination of carnitine and antioxidant polyphenols
LT2918286T (en) Pharmaceutical preparation containing insulin in crystalline as well as in solubilized form
PL373624A1 (en) 4-[7-halo-2-quino (xa-) linyloxy]phenoxy-propionic acid derivatives as antineoplastic agents
PL1638582T3 (en) Use of hyaluronic acid for preparing compositions for treating recurrent oral cavity aphthas
AU2003262185A1 (en) Pre-and post therapy gene expression profiling to identify drug targets
AU2003205717A1 (en) New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
AU2003272945A1 (en) Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction
AU2003210419A1 (en) Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophtalmic topical use capable of improving the level of l-ascorbic acid in the eye
SI1485084T1 (en) Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye
EP1421940A4 (en) Medical composition for external use for dermatosis
IL182835A0 (en) Process for and imtermediates in the preparaition of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
AU2003222667A1 (en) 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases
IL171636A (en) Pharmaceutical compositions containing a plasminogen activating factor for use in the treatment of stroke
AU2003282619A1 (en) Use of stable glutamine derivatives to improve drug absorption
PL1646378T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences